(lp0
S"Momenta Pharmaceuticals, Inc. Earnings Take a Back Seat Motley Fool - Feb 22, 2017 Momenta Pharmaceuticals  reported fourth-quarter earnings on Tuesday, but analysts weren't discussing the numbers.SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ... - PR Newswire "
p1
aS'Why Momenta Pharmaceuticals, Inc. Jumped Higher Today Motley Fool - Oct 11, 2016 Before then, it seems likely Momenta will try and partner M923 . Last month, Momenta announced that it will regain rights to the drug from Shire.Momenta Pharmaceuticals  Stock Surges, Barclays Upgrades - TheStreet.com'
p2
aS'Why Momenta Pharmaceuticals, Inc. Stock Skyrocketed Higher Today Motley Fool - Jan 31, 2017 Shares of Momenta Pharmaceuticals  are up over 20% at 12:28 p.m. EST after the company announced that the U.S.Momenta Pharmaceuticals Inc.  Surged To A New High On Patent Ruling - RTT News'
p3
aS"Momenta Pharmaceuticals Announces FDA Warning Letter to Contracted Glatopa ... GlobeNewswire  - Feb 17, 2017 CAMBRIDGE, Mass., Feb. 17, 2017  -- Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Sandoz's contracted&nbsp;...Momenta Pharma shares halted as drug application hits speed bump - MarketWatchMomenta halted after noting compliance issue in drug application - Seeking Alpha"
p4
aS'Momenta Pharmaceuticals Appoints Scott M. Storer as Senior Vice President and ... GlobeNewswire  - Nov 2, 2016 CAMBRIDGE, Mass., Nov. 02, 2016  -- Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of Scott M.Mylan, Momenta move ahead in trial for rheumatoid arthritis drug - Pittsburgh Business Times'
p5
aS"Tuesday's Market Insights: DryShips Inc. , Momenta Pharmaceuticals, Inc ... Smarter Analyst - Feb 21, 2017 Momenta Pharmaceuticals, Inc.  shares are trading down 14% after the complex pharmaceutical company announced that a warning letter had been delivered from the FDA to Pfizer, Sandoz's contracted manufacturer for Glatopa, a drug&nbsp;..."
p6
aS'Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2016 ... GlobeNewswire  - Feb 7, 2017 CAMBRIDGE, Mass., Feb. 07, 2017  -- Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the fourth&nbsp;...'
p7
aS"Momenta Pharmaceuticals, Inc.: Good News from Courts and the FDA Ahead? Motley Fool - Aug 9, 2016 While the report included sales of Momenta's and partner Novartis AG's  Glatopa, the generic version of Teva Pharmaceutical Industries'  once-daily Copaxone, investors should focus on the potential approval of the generic&nbsp;..."
p8
aS'A Somewhat Murky Outlook For Momenta Pharmaceuticals Seeking Alpha - Dec 28, 2016 Although I have made some good gains from Momenta Pharmaceuticals over the past few months, it is one of the murkiest companies I follow in the biotech space.'
p9
aS'The Momenta Pharmaceuticals, Inc.  Lifted to Buy at Zacks Investment ... Petro Global News 24 - 9 hours ago Zacks Investment Research upgraded shares of Momenta Pharmaceuticals, Inc.  from a hold rating to a buy rating in a report published on Wednesday.Momenta Pharmaceuticals, Inc.  Recent Ownership Changes - Post AnalystMomenta Pharmaceuticals, Inc.  Broker Price Targets For The ... - Fiscal Standard'
p10
a.